Cargando…

Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes

Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Haberger, Markus, Bomans, Katrin, Diepold, Katharina, Hook, Michaela, Gassner, Jana, Schlothauer, Tilman, Zwick, Adrian, Spick, Christian, Kepert, Jochen Felix, Hienz, Brigitte, Wiedmann, Michael, Beck, Hermann, Metzger, Philipp, Mølhøj, Michael, Knoblich, Constanze, Grauschopf, Ulla, Reusch, Dietmar, Bulau, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984323/
https://www.ncbi.nlm.nih.gov/pubmed/24441081
http://dx.doi.org/10.4161/mabs.27876
_version_ 1782311441221550080
author Haberger, Markus
Bomans, Katrin
Diepold, Katharina
Hook, Michaela
Gassner, Jana
Schlothauer, Tilman
Zwick, Adrian
Spick, Christian
Kepert, Jochen Felix
Hienz, Brigitte
Wiedmann, Michael
Beck, Hermann
Metzger, Philipp
Mølhøj, Michael
Knoblich, Constanze
Grauschopf, Ulla
Reusch, Dietmar
Bulau, Patrick
author_facet Haberger, Markus
Bomans, Katrin
Diepold, Katharina
Hook, Michaela
Gassner, Jana
Schlothauer, Tilman
Zwick, Adrian
Spick, Christian
Kepert, Jochen Felix
Hienz, Brigitte
Wiedmann, Michael
Beck, Hermann
Metzger, Philipp
Mølhøj, Michael
Knoblich, Constanze
Grauschopf, Ulla
Reusch, Dietmar
Bulau, Patrick
author_sort Haberger, Markus
collection PubMed
description Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected.
format Online
Article
Text
id pubmed-3984323
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-39843232014-04-18 Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes Haberger, Markus Bomans, Katrin Diepold, Katharina Hook, Michaela Gassner, Jana Schlothauer, Tilman Zwick, Adrian Spick, Christian Kepert, Jochen Felix Hienz, Brigitte Wiedmann, Michael Beck, Hermann Metzger, Philipp Mølhøj, Michael Knoblich, Constanze Grauschopf, Ulla Reusch, Dietmar Bulau, Patrick MAbs Report Modifications like asparagine deamidation, aspartate isomerization, methionine oxidation, and lysine glycation are typical degradations for recombinant antibodies. For the identification and functional evaluation of antibody critical quality attributes (CQAs) derived from chemical modifications in the complementary-determining regions (CDRs) and the conserved regions, an approach employing specific stress conditions, elevated temperatures, pH, oxidizing agents, and forced glycation with glucose incubation, was applied. The application of the specific stress conditions combined with ion exchange chromatography, proteolytic peptide mapping, quantitative liquid chromatography mass spectrometry, and functional evaluation by surface plasmon resonance analysis was adequate to identify and functionally assess chemical modification sites in the CDRs of a recombinant IgG1. LC-Met-4, LC-Asn-30/31, LC-Asn-92, HC-Met-100c, and HC Lys-33 were identified as potential CQAs. However, none of the assessed degradation products led to a complete loss of functionality if only one light or heavy chain of the native antibody was affected. Landes Bioscience 2014-03-01 2014-01-17 /pmc/articles/PMC3984323/ /pubmed/24441081 http://dx.doi.org/10.4161/mabs.27876 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Report
Haberger, Markus
Bomans, Katrin
Diepold, Katharina
Hook, Michaela
Gassner, Jana
Schlothauer, Tilman
Zwick, Adrian
Spick, Christian
Kepert, Jochen Felix
Hienz, Brigitte
Wiedmann, Michael
Beck, Hermann
Metzger, Philipp
Mølhøj, Michael
Knoblich, Constanze
Grauschopf, Ulla
Reusch, Dietmar
Bulau, Patrick
Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title_full Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title_fullStr Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title_full_unstemmed Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title_short Assessment of chemical modifications of sites in the CDRs of recombinant antibodies: Susceptibility vs. functionality of critical quality attributes
title_sort assessment of chemical modifications of sites in the cdrs of recombinant antibodies: susceptibility vs. functionality of critical quality attributes
topic Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984323/
https://www.ncbi.nlm.nih.gov/pubmed/24441081
http://dx.doi.org/10.4161/mabs.27876
work_keys_str_mv AT habergermarkus assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT bomanskatrin assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT diepoldkatharina assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT hookmichaela assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT gassnerjana assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT schlothauertilman assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT zwickadrian assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT spickchristian assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT kepertjochenfelix assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT hienzbrigitte assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT wiedmannmichael assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT beckhermann assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT metzgerphilipp assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT mølhøjmichael assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT knoblichconstanze assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT grauschopfulla assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT reuschdietmar assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes
AT bulaupatrick assessmentofchemicalmodificationsofsitesinthecdrsofrecombinantantibodiessusceptibilityvsfunctionalityofcriticalqualityattributes